雾化吸入阿米卡星治疗多重耐药铜绿假单胞菌肺炎疗效观察  

作　　者：牟照红[1] 许伟宁[1] 

机构地区：[1]辽宁省大连市第二人民医院呼吸内科,辽宁大连116011

出　　处：《药物与人》2014年第10期75-75,共1页Medicine & People

摘　　要：目的：对雾化吸八阿米卡星这一治疗手段在多重耐药铜绿假单胞菌肺炎这一痰病中的治疗效果进行探讨。方法：选取同期于我院治疗多重耐药铜绿假单胞菌肺炎患者40例，并保证这40例患者均使用呼吸机进行治疗，将这40例患者作为研究对象，并随机均等分为实验组和对照组，对对照组患者采取头孢哌酮舒巴坦（辉瑞舒普深）；实验组的患者在此基础上加用雾化吸入治疗。结果：实验纽患者的临床好转率为95o％，对照组为70．o％，数据具有统计学差异（P〈0．05）结论：阿米卡星雾化吸入在多重耐药铜绿假单胞菌肺炎这一疾病的治疗上可以取得较好的疗效，而且安全性方面有保障。to the atomization inhalation amikacin therapy in multiple drug resistant pseudomonas aeruginosa pneumonia treatment of this disease were discussed. Method： choose the same period in the hospital treatment of multiple drug resistance of pseudomonas aeruginosa pneumonia and using breathing machine 40 cases of patients, the 40 patients as the research object, and equal randomly divided into experimental group and control group, the control group patients to eefoperazone shu ba temple （Pfizer shope deep） On the basis of the experimental group of patients with atomization inhalation therapy. Results： clinical, the experimental group patients was 95.0N, the control group was 70.0 ~, the data statistically difference （P % 0.05） conclusion~ amikaein atomization inhalation in multiple drug resistant pseudomonas aeruginosa pneumonia on the treatment of this disease can obtain good curative effect, and safety guaranteed.

关 键 词：阿米卡星 雾化吸入 多重耐药铜绿假单胞菌肺爽 

分 类 号：R96[医药卫生—药理学]